In our study, we comprehensively analyzed the role of TPD52L2 using pan-cancer data from TCGA database in 33 cancers, including expression, prognostic values, DNA methylation, copy number alteration (CNA), and mutation status of TPD52L2. Here, TPD52L2 is linked to cancer.